TrialThe Journal of clinical investigation2011

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.

Yun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.